Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.76M Sell
17,538
-2,137
-11% -$767K 0.18% 82
2025
Q4
$6.92M Sell
19,675
-96
-0.5% -$35K 0.2% 81
2025
Q3
$7.31M Sell
19,771
-1,911
-9% -$738K 0.22% 76
2025
Q2
$8.58M Sell
21,682
-931
-4% -$348K 0.28% 72
2025
Q1
$8.42M Buy
+22,613
New +$8.61M 0.35% 71
2024
Q4
Sell
-50
Closed -$18.1K 419
2024
Q3
$18.1K Buy
50
+35
+233% +$12.1K ﹤0.01% 303
2024
Q2
$5.1K Hold
15
﹤0.01% 308
2024
Q1
$5.37K Buy
+15
New +$5.05K ﹤0.01% 314

Other funds holding SYK

BNP Paribas's SYK Position: Q1 2026 in Review

BNP Paribas reduced its Stryker (SYK) stake by 11% in Q1 2026, selling an estimated $767K and leaving 17,538 shares worth $5.76M. The position accounts for 0.18% of the portfolio, ranked #82.

BNP Paribas first reported a position in SYK in Q1 2024 and has held it in 8 quarters since. The position peaked at $8.58M in Q2 2025. 2,295 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • BNP Paribas held 17,538 shares of Stryker worth $5.76M as of Q1 2026.
  • BNP Paribas sold 2,137 Stryker shares in Q1 2026, an estimated $767K.
  • Stryker made up 0.18% of BNP Paribas's portfolio in Q1 2026, its #82 holding.
  • BNP Paribas first reported a position in Stryker in Q1 2024 and has held it in 8 quarters since.
  • BNP Paribas's Stryker position peaked at $8.58M in Q2 2025.
  • 2,295 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on BNP Paribas's 13F filing for Q1 2026, filed 12 May 2026.